Form 10 Explorer
10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC

BKYI

NASDAQ

CIK: 1019034

File #: 1-13463

Period End: Sep 30, 2023

Fiscal Year: 2023

View on EDGAR
Balance Sheet
42 line items · 2 periods
XBRL
ItemSep 30, 2023Dec 31, 2022
ASSETS
Cash and cash equivalents
307,0862,635,522
Accounts receivable, net
2,799,2181,522,784
Due from factor
62,57249,500
Inventory
4,289,2134,434,369
Prepaid expenses and other
362,250342,706
Total current assets
7,820,3398,984,881
Equipment and leasehold improvements, net
69,202107,413
Capitalized contract costs, net
264,348283,069
Deposits and other assets
08,712
Deferred offering costs
25,4340
Operating lease right-of-use assets
50,465197,355
Approximation
50,465
Intangible assets, net
1,519,5921,762,825
Total non-current assets
1,929,0412,359,374
TOTAL ASSETS
9,749,38011,344,255
LIABILITIES
Accounts payable
1,656,1071,108,279
Accrued liabilities
1,080,0321,009,123
Income taxes payable
162,8110
Convertible note payable
2,331,4972,596,203
Government loan – BBVA Bank, current portion
135,308120,000
Deferred revenue, current
610,451462,418
Operating lease liabilities, current portion
51,746159,665
Total current liabilities
6,027,9525,455,688
Deferred revenue, long term
32,35452,134
Deferred tax liability
152,998170,281
Government loan – BBVA Bank – net of current portion
221,625326,767
Operating lease liabilities, net of current portion
037,829
Total non-current liabilities
406,977587,011
TOTAL LIABILITIES
6,434,9296,042,699
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 9,501,669 and 9,190,504 of $.0001 par value at September 30, 2023 and December 31, 2022, respectively
950919
Additional paid-in capital
122,263,106122,028,612
Accumulated other comprehensive loss
(115,208)(242,602)
Accumulated deficit
(118,834,397)(116,485,373)
TOTAL STOCKHOLDERS’ EQUITY
3,314,4515,301,556
Common Stock
950919
Additional Paid-in Capital
122,263,106122,028,612
AOCI Attributable to Parent
(115,208)(242,602)
Retained Earnings
(118,834,397)(116,485,373)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
9,749,38011,344,255